69975-65-1

Usage

InChI:InChI=1/C9H9NO/c10-7-3-1-6-2-4-9(11)8(6)5-7/h1,3,5H,2,4,10H2

Upstream product

• 83-33-0 inden-1-one 
• 24623-25-4 4-nitro-2,3-dihydro-1H-inden-1-one 
• 24623-24-3 6-nitroindan-1-one 

Downstream Products

• 62803-47-8 6-hydroxy-1-indanone 
• 128924-75-4 C₁₇H₁₆N₂O₄S 
• 69975-66-2 1-oxo-6-indanecarbonitrile 
• 14548-38-0 6-chloro-1-indanone 
• 681246-49-1 6-amino-7-bromo-2,3-dihydro-1H-inden-1-one 
• 897374-02-6 6-hydrazinoindan-1-one 
• 14548-39-1 6-bromoindan-1-one 
• 14548-40-4 6-iodo-2,3-dihydro-1H-inden-1-one 
• 511533-24-7 ethyl 7-chloro-1-(2',4'-dichlorophenyl)-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxylate 
• 511533-12-3 7-chloro-1-(2',4'-dichlorophenyl)-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxylic acid 

Relevant academic research and scientific papers

METHODS FOR MAKING QUINOLINYLDIAMINES

The present disclosure provides methods for making quinolinyldiamine products from quinolinyl starting materials. In addition, the quinolinyldiamines can be used as ligands or ligand precursors for catalysts, e.g. for use in olefin polymerization.

Sulfonamides having antiangiogenic and anticancer activity

Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.